Ranibizumab (ophthalmic)

Ranibizumab (ophthalmic)

Ranibizumab (ophthalmic)

What is ranibizumab?

Ranibizumab can also be used in adults to treat diabetic retinopathy and myopia, which are caused by abnormal growth of new blood vessels in the retina.

Ranibizumab may also be used for purposes not listed in this medication guide.

Ranibizumab side effects

If necessary, get emergency medical helpSigns of an allergic reaction: Hives, difficulty breathing, swelling of the face, lips, tongue or throat.

Ranibizumab can cause serious side effects. Call your doctor immediately if you have:

• increased eye pain, swelling or redness of your eye;

• loss of vision, sensitivity to light;

• blurred vision, seeing halos around lights;

• the feeling that something is in your eye;

• discharge or watery eyes;

• sudden changes in your vision, seeing flashes of light; or

• a “spider web” appearance in your vision.

Common ranibizumab side effects may include:

• eye pain;

• sensitivity to light;

• “Swimming” in your vision;

• increased intraocular pressure; or

• Eye redness or a spot of blood in the white of your eye.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You can report side effects to FDA at 1-800-FDA-1088.

Warnings

You should not receive ranibizumab if you have swelling, redness, pain in your eyes, or any type of infection in or around your eyes.

Call your doctor immediately if you suddenly have vision problems, eye pain, redness, discharge, or watering in your eyes, or if your eyes become more sensitive to light.

Before you take this medicine

You should not receive ranibizumab if you are allergic to it or if you have:

• swelling, redness, pain in or around your eyes; or

• any type of infection in or around your eyes.

Tell your doctor if you have or have ever had:

• an eye infection;

• retinal detachment;

• a heart attack or stroke;

• glaucoma or another condition that increases pressure in your eyes; or

• have taken certain other medicines that may increase the risk of bleeding, such as: B. Warfarin, aspirin or non-steroidal anti-inflammatory drugs (NSAIDs).

It is not known whether ranibizumab will harm an unborn baby. Use effective contraception while using ranibizumab and for at least 12 months after your last dose. Tell your doctor if you are pregnant or planning to become pregnant.

Ask a doctor if it is safe to breastfeed while using ranibizumab.

How is ranibizumab administered?

Follow all instructions on your prescription label and read any medication guides or instructions for use.

Ranibizumab injection is given as an injection into the eye. Your doctor will use medicine to numb your eye before the injection. You will receive this injection in your doctor's office or other clinical setting.

The ranibizumab eye implant is inserted through the white part of the eye by your doctor, which refills your implant every 6 months.

If you have a ranibizumab eye implant, talk to your doctor when you have an MRI (magnetic resonance imaging) appointment.

Your eyes will be examined to make sure ranibizumab hasn't caused any serious side effects.

Call your doctor immediately if you notice thisEye implantis out of place.

Wash your hands first if you have to rub your eyes or touch the area where the eyes areEye implantis located.

Ranibizumab dosage information

Usual adult dosage for macular degeneration:

0.5 mg as an intravitreal injection once a month (approximately 28 days)

Use: Neovascular (wet) age-related macular degeneration (AMD)

Usual Adult Dose for Diabetic Retinopathy:

-DME and diabetic retinopathy with DME:
0.3 mg as an intravitreal injection once a month (approximately 28 days)

-Macular edema after RVO:
0.5 mg as an intravitreal injection once a month (approximately 28 days)

Use: Diabetic Macular Edema (DME); diabetic retinopathy with DME; Macular edema after retinal vein occlusion (RVO)

Usual adult dosage for macular edema:

-DME and diabetic retinopathy with DME:
0.3 mg as an intravitreal injection once a month (approximately 28 days)

-Macular edema after RVO:
0.5 mg as an intravitreal injection once a month (approximately 28 days)

Use: Diabetic Macular Edema (DME); diabetic retinopathy with DME; Macular edema after retinal vein occlusion (RVO)

What happens if I miss a dose?

Call your doctor for instructions if you miss an appointment for your ranibizumab injection.

What happens if I overdose?

In the medical field, an overdose would be treated quickly.

What should I avoid after taking ranibizumab?

Avoid driving and dangerous activities until eye protection can be removed and you can see clearly.

What other drugs affect ranibizumab?

Medications you use in the eyes are unlikely to be affected by other medications you are taking. But many medications can interact. Tell your doctor about all your current medications, including prescription and over-the-counter medications, vitamins, and herbal products.

More information

Remember to keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medicine only for the prescribed indication.